Valentine, William J.
Ossian Health Economics and Communications GmbH Basel Switzerland
7 papers on CoChatORCID 0000-0003-4844-6813
Most cited papers
- Verified
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom
Palmer, A. J., Roze, S., Valentine, W. J., Spinas, G. A., Shaw, J. E., & Zimmet, P. Z. (2004) · Clinical Therapeutics
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 128
- Verified
Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
Roze, S., Smith‐Palmer, J., Valentine, W., de Portu, S., Nørgaard, K., & Pickup, J. C. (2015) · Diabetic Medicine
Diabetes Management and ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 77
- Verified
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
Bain, S. C., Bekker Hansen, B., Hunt, B., Chubb, B., & Valentine, W. J. (2020) · Journal of Medical Economics
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 53
- Verified
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States
Valentine, W. J., Hoog, M., Mody, R., Belger, M., & Pollock, R. (2023) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 28
- Verified
Long-term cost-effectiveness of two GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus in the Italian setting: Liraglutide versus lixisenatide
Hunt, B., Kragh, N., McConnachie, C. C., Valentine, W. J., Rossi, M. C., & Montagnoli, R. (2017) · Clinical Therapeutics
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 24
- Verified
An estimation of the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in the UK
Pratoomsoot, C., Smith, H. T., Kalsekar, A., Boye, K. S., Arellano, J., & Valentine, W. J. (2009) · Diabetic Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and Research
Cited by 18
- Verified
Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi‐annals initiative: a long‐term cost‐effectiveness analysis
Giorda, C. B., Nicolucci, A., Pellegrini, F., Kristiansen, C. K., Hunt, B., Valentine, W. J., & Vespasiani, G. (2014) · Diabetic Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free